Status:

UNKNOWN

The Short-term Efficacy of Novel NTDP-RFA in the Treatment of Small HCC With Cirrhosis.

Lead Sponsor:

Southwest Hospital, China

Conditions:

Hepatocellular Carcinoma Stage I

Radiofrequency Ablation

Eligibility:

All Genders

18-70 years

Brief Summary

To evaluate the short-term efficacy of novel no-touch combined directional perfusion radiofrequency ablation in the treatment of small hepatocellular carcinoma with cirrhosis.

Detailed Description

Liver cancer is the fourth leading cause of cancer-related deaths globally. Hepatocellular carcinoma (HCC) accounts for 70% to 85% of primary HCC and is the leading cause of death in patients with cir...

Eligibility Criteria

Inclusion

  • Primary hepatocellular carcinoma with a background of cirrhosis
  • Single shot with diameter ≤ 3cm
  • The tumor did not invade portal vein, hepatic vein trunk and secondary branches
  • Child Pugh A/B
  • ICG-R15 ≤ 30%
  • 18-70 years old
  • The follow-up time reached 2 years

Exclusion

  • The follow-up time is less than 2 years
  • multiple lesions or diameter \> 3cm
  • Previous history of upper gastrointestinal bleeding or severe hypersplenism
  • Patients with extrahepatic or lymph node metastasis
  • Wish to receive liver transplantation and hepatectomy
  • The lesion is adjacent to the gallbladder, important blood vessels and bile ducts in the hilum of the liver and important organs around
  • severe bleeding tendency, platelet count \< 50 × 10\^9/L, or prothrombin time prolonged \> 3s
  • Other anti-tumor therapies were accepted before surgery

Key Trial Info

Start Date :

January 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 31 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04513119

Start Date

January 1 2017

End Date

August 31 2022

Last Update

August 14 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Institute of hepatobiliary surgery,Southwest Hospital

Chongqing, Chongqing Municipality, China, 400038

2

Institute of hepatobiliary surgery,Southwest Hospital

Chongqing, Chongqing Municipality, China, 400038